3,4-二溴苯甲醛 、 肼甲酰亚胺酰胺一氯化氢 以to give the title compound (3093) as a white powder (655 mg, 92%)的产率得到2-[(3,4-dibromophenyl)methylene]hydrazine carboximidamide hydrochloride
参考文献:
名称:
Treating neuropathic pain with neuropeptide FF receptor 2 agonists
Discovery of Selective Nonpeptidergic Neuropeptide FF2 Receptor Agonists
作者:Gilles Gaubert、Fabio Bertozzi、Nicholas M. Kelly、Jan Pawlas、Audra L. Scully、Norman R. Nash、Luis R. Gardell、Jelveh Lameh、Roger Olsson
DOI:10.1021/jm9011998
日期:2009.11.12
We report the discovery and initial characterization of a novel class of selective NPFF2 agonists. HTS screening using R-SAT, a whole cell based functional assay, identified a class of aryliminoguanidines as NPFF1 and NPFF2 ligands. Subsequent optimization led to molecules exhibiting selective NPFF2 agonistic activity. Systemic administration showed that selective NPFF2 agonists (1 and 3)are active in various pain models in vivo, whereas administration of it nonselective NPFF1 and NPFF2 agonist (9) increases sensitivity to noxious and non-noxious stimuli.
Treating neuropathic pain with neuropeptide FF receptor 2 agonists
申请人:Scully L. Audra
公开号:US20050136444A1
公开(公告)日:2005-06-23
The invention described below relates to the discovery of the neuropeptide FF receptor subtype that mediates acute nociception and chronic neuropathic pain, compounds that selectively interact with this receptor subtype and methods for treating acute pain and chronic neuropathic pain.